Lanxess (LXS) PT Set at €53.00 by UBS Group
UBS Group set a €53.00 ($61.63) price objective on Lanxess (ETR:LXS) in a research note published on Monday, www.boersen-zeitung.de reports. The firm currently has a neutral rating on the stock.
Other equities research analysts also recently issued research reports about the stock. Citigroup set a €80.00 ($93.02) price objective on shares of Lanxess and gave the stock a buy rating in a research note on Friday, September 21st. Goldman Sachs Group set a €86.00 ($100.00) price objective on shares of Lanxess and gave the stock a buy rating in a research note on Thursday, September 20th. Kepler Capital Markets set a €86.00 ($100.00) price objective on shares of Lanxess and gave the stock a buy rating in a research note on Wednesday, September 19th. Nord/LB set a €62.00 ($72.09) price target on shares of Lanxess and gave the stock a buy rating in a research note on Monday, November 12th. Finally, Cfra set a €65.00 ($75.58) price target on shares of Lanxess and gave the stock a buy rating in a research note on Tuesday, November 13th. Four equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have given a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of €64.63 ($75.15).
Shares of Lanxess stock opened at €45.18 ($52.53) on Monday. Lanxess has a 1 year low of €59.89 ($69.64) and a 1 year high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Featured Article: How to calculate the intrinsic value of a stock
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.